^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Title:

AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small Cell Lung Cancer

Published date:
11/17/2020
Excerpt:
AMG 757 showed potent and specific killing of even those SCLC cell lines with very low DLL3 expression (<1,000 molecules per cell). 
DOI:
10.1158/1078-0432.CCR-20-2845